CoChat
Sign Up
Cited by 213

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway

Hocevar, Barbara A., Smine, Abdelkrim, Xu, Xiang‐Xi, Howe, Philip H.·2001·The EMBO Journal
DOI 10.1093/emboj/20.11.2789
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emboj/20.11.2789

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. Borg J‐P, Ooi J, Levy E and Margolis B (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol, 16, 6229–6241. · DOI · Paper page
  2. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA,Jr and Topper JN (1999) MEKK‐1, a component of the stress (stress‐activated protein kinase/c‐Jun N‐terminal kinase) pathway, can selectively activate Smad2‐mediated transcriptional activation in endothelial cells. J Biol Chem, 274, 8797–8805. · DOI
  3. Carcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L and Massagué J (1994) Type I receptors specify growth‐inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol, 14, 3810–3821.
  4. Chen X, Rubock MJ and Whitman M (1996) A transcriptional partner for MAD proteins in TGF‐β signalling. Nature, 383, 691–696. · DOI
  5. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB and Lechleider RJ (1998) Smad2 transduces common signals from receptor serine‐threonine and tyrosine kinases. Genes Dev, 12, 1587–1592. · DOI
  6. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier J‐M (1998) Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene. EMBO J, 17, 3091–3100. · DOI
  7. Dho SE, Jacob S, Wolting CD, French MB, Rohrschneider LR and McGlade CJ (1998) The mammalian numb phosphotyrosine‐binding domain. Characterization of binding specificity and identification of a novel PDZ domain‐containing numb binding protein, LNX. J Biol Chem, 273, 9179–9187. · DOI
  8. Doré JJE,Jr, Edens M, Garamszegi N and Leof EB (1998) Heteromeric and homomeric transforming growth factor‐β receptors show distinct signaling and endocytic responses in epithelial cells. J Biol Chem, 273, 31770–31777. · DOI
  9. Engel ME, McDonnell MA, Law BK and Moses HL (1999) Interdependent SMAD and JNK signaling in transforming growth factor‐β‐mediated transcription. J Biol Chem, 274, 37413–37420. · DOI
  10. Fazili Z, Sun W, Mittelstaedt S, Cohen C and Xu X‐X (1999) Disabled‐2 inactivation is an early step in ovarian tumorigenicity. Oncogene, 18, 3104–3113. · DOI · Paper page
  11. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng S‐W, Szepesi J and Mok SC (1998) DOC‐2/hDAB2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene, 17, 419–424. · DOI
  12. Heldin CH, Miyazono K and ten Dijke P (1997) TGF‐β signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465–471. · DOI
  13. Hocevar BA and Howe PH (1996) Isolation and characterization of mutant cell lines defective in transforming growth factor β signaling. Proc Natl Acad Sci USA, 93, 7655–7660. · DOI
  14. Hocevar BA, Brown TL and Howe PH (1999) TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway. EMBO J, 18, 1345–1356. · DOI
  15. Howe PH, Cunningham MR and Leof EB (1990) Inhibition of mink lung epithelial cell proliferation by transforming growth factor‐β is coupled through a pertussis‐toxin‐sensitive substrate. Biochem J, 266, 537–543. · DOI
  16. Howell BW, Lanier LM, Frank R, Gertler FB and Cooper JA (1999) The disabled 1 phosphotyrosine‐binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol Cell Biol, 19, 5179–5188. · DOI · Paper page
  17. Kavanaugh WM, Turck CW and Williams LT (1995) PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science, 268, 1177–1179. · DOI
  18. Labbe E, Silvestri C, Hoodless PA, Wrana JL and Attisano L (1998) Smad2 and Smad3 positively and negatively regulate TGFβ‐dependent transcription through the forkhead DNA‐binding protein FAST2. Mol Cell, 2, 109–120. · DOI
  19. Le Dai J, Turnacioglu KK, Schutte M, Sugar AY and Kern SE (1998) Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res, 58, 4592–4597.
  20. Lee YJ et al. (1997) TGF‐β suppresses IFN‐γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol, 158, 2065–2075. · DOI
  21. Li S‐C, Zwahlen C, Vincent SJF, McGlade CJ, Kay LE, Pawson T and Forman‐Kay JD (1998) Structure of a Numb PTB domain–peptide complex suggests a basis for diverse binding specificity. Nature Struct Biol, 5, 1075–1083. · DOI
  22. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA and Lodish HF (1997) Transforming growth factor β‐induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA, 94, 10669–10674. · DOI
  23. Macías‐Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L and Wrana JL (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87, 1215–1224. · DOI
  24. Massagué J (1998) TGF‐β signal transduction. Annu Rev Biochem, 67, 753–791. · DOI
  25. Mok SC, Wong K‐K, Chan RKW, Lau CC, Tsao S‐W, Knapp RC and Berkowitz RS (1994) Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol, 52, 247–252. · DOI · Paper page
  26. Mok SC et al. (1998) DOC‐2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene, 16, 2381–2387. · DOI · Paper page
  27. Morris SM and Cooper JA (2001) Disabled‐2 colocalizes with the LDLR in clathrin‐coated pits and interacts with AP‐2. Traffic, 2, 111–123. · DOI · Paper page
  28. Oleinikov AV, Zhao J and Makker SP (2000) Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem J, 347, 613–621. · DOI · Paper page
  29. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J and Lax I (2000) FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol, 20, 979–989. · DOI
  30. Patil S, Wildey GM, Brown TL, Choy L, Derynck R and Howe PH (2000) Smad7 is induced by CD40 and protects WEHI 231 B‐lymphocytes from TGFβ‐induced growth inhibition and apoptosis. J Biol Chem, 275, 38363–38370. · DOI
  31. Pawson T and Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075–2080. · DOI · Paper page
  32. Piek E, Heldin C‐H and Dijke PT (1999) Specificity, diversity, and regulation in TGF‐β superfamily signaling. FASEB J, 13, 2105–2124. · DOI
  33. Schwahn DJ and Medina D (1998) p96, a MAPK‐related protein, is consistently downregulated during mouse mammary carcinogenesis. Oncogene, 17, 1173–1178. · DOI · Paper page
  34. Tseng C‐P, Ely BD, Li Y, Pong R‐C and Hsieh H‐T (1998) Regulation of rat DOC‐2 gene during castration‐induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology, 139, 3542–3553. · DOI · Paper page
  35. Tsukazaki T, Chiang TA, Davison AF, Attisano L and Wrana JL (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell, 95, 779–791. · DOI
  36. van der Geer P and Pawson T (1995) The PTB domain: a new protein module implicated in signal transduction. Trends Biochem Sci, 20, 277–280. · DOI
  37. Wieser R, Wrana JL and Massagué J (1995) GS domain mutations that constitutively activate TβR‐I, the downstream signaling component in the TGF‐β receptor complex. EMBO J, 14, 2199–2208. · DOI
  38. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF and Massagué J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003–1014. · DOI
  39. Wrana JL, Attisano L, Wieser R, Ventura F and Massagué J (1994) Mechanism of activation of the TGF‐β receptor. Nature, 370, 341–347. · DOI
  40. Xu L, Chen Y‐G and Massagué J (2000) The nuclear import function of Smad2 is masked by SARA and unmasked by TGFβ‐dependent phosphorylation. Nature Cell Biol, 2, 559–562. · DOI
  41. Xu X‐X, Yang W, Jackowski S and Rock CO (1995) Cloning of a novel phosphoprotein regulated by colony‐stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem, 270, 14184–14191. · DOI · Paper page
  42. Xu X‐X, Yi T, Tang B and Lambeth JD (1998) Disabled‐2 (Dab2) is an SH3 domain‐binding partner of Grb2. Oncogene, 16, 1561–1569. · DOI
  43. Yajnik V, Blaikie P, Bork P and Margolis B (1996) Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction. J Biol Chem, 271, 1813–1816. · DOI
  44. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW and Schreiber SL (1994) Structural basis for the binding of proline‐rich peptides to SH3 domains. Cell, 76, 933–945. · DOI
  45. Zawel L, Le Dai J, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B and Kern SE (1998) Human Smad3 and Smad4 are sequence‐specific transcription activators. Mol Cell, 1, 611–617. · DOI
  46. Zhang Y and Derynck R (1999) Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol, 9, 274–279. · DOI
  47. Zhang Y, Feng X, We R and Derynck R (1996) Receptor‐associated Mad homologues synergize as effectors of the TGF‐β response. Nature, 383, 168–172. · DOI
  48. Zhou M‐M et al. (1995) Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature, 378, 584–592. · DOI

Cited by

Sorted by citations

Metadata

Authors
Hocevar, B. A., Smine, A., Xu, X., & Howe, P. H.
Venue
The EMBO Journal
Publisher
Springer Science and Business Media LLC
Published
2001-06-01
Volume
20
Issue
11
Pages
2789-2801
ISSN
  • 0261-4189
  • 1460-2075
DOI
10.1093/emboj/20.11.2789
Cited by
213
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review